Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.003 | 0.003 |
Onchocerca volvulus | 0.0018 | 0.003 | 0.003 | |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0048 | 0.0736 | 0.5 |
Loa Loa (eye worm) | TK/ALK protein kinase | 0.0018 | 0.003 | 0.003 |
Brugia malayi | glutathione reductase | 0.014 | 0.2871 | 0.2871 |
Brugia malayi | galectin | 0.0445 | 1 | 1 |
Echinococcus multilocularis | Galectin, carbohydrate recognition domain | 0.0445 | 1 | 1 |
Brugia malayi | Galactoside-binding lectin family protein | 0.0445 | 1 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0036 | 0.0435 | 0.0435 |
Plasmodium falciparum | glutathione reductase | 0.014 | 0.2871 | 1 |
Brugia malayi | Thioredoxin reductase | 0.014 | 0.2871 | 0.2871 |
Leishmania major | trypanothione reductase | 0.014 | 0.2871 | 1 |
Brugia malayi | Galactoside-binding lectin family protein | 0.0445 | 1 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0109 | 0.2146 | 0.2146 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0048 | 0.0736 | 0.5 |
Onchocerca volvulus | Galectin homolog | 0.0445 | 1 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0048 | 0.0736 | 0.0736 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0048 | 0.0736 | 0.5 |
Treponema pallidum | NADH oxidase | 0.0048 | 0.0736 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.2146 | 0.2146 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 1 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.014 | 0.2871 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.014 | 0.2871 | 1 |
Loa Loa (eye worm) | galectin | 0.0445 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.003 | 0.003 |
Brugia malayi | Trypsin family protein | 0.0109 | 0.2146 | 0.2146 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0048 | 0.0736 | 0.0736 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.003 | 0.003 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.2146 | 0.2146 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0115 | 0.2293 | 0.2293 |
Trypanosoma brucei | trypanothione reductase | 0.014 | 0.2871 | 1 |
Onchocerca volvulus | Galectin homolog | 0.0445 | 1 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0048 | 0.0736 | 0.5 |
Loa Loa (eye worm) | galactoside-binding lectin family protein | 0.0445 | 1 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0048 | 0.0736 | 0.0708 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0036 | 0.0435 | 0.0435 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.003 | 0.003 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.003 | 0.003 |
Brugia malayi | galectin | 0.0445 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0048 | 0.0736 | 0.5 |
Brugia malayi | Galactoside-binding lectin family protein | 0.0445 | 1 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.014 | 0.2871 | 0.2871 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0048 | 0.0736 | 0.5 |
Onchocerca volvulus | 0.0109 | 0.2146 | 0.2146 | |
Echinococcus granulosus | Galectin carbohydrate recognition domain | 0.0445 | 1 | 1 |
Onchocerca volvulus | 0.01 | 0.1937 | 0.1937 | |
Onchocerca volvulus | 0.0018 | 0.003 | 0.003 | |
Loa Loa (eye worm) | galectin | 0.0445 | 1 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.014 | 0.2871 | 0.2871 |
Plasmodium vivax | glutathione reductase, putative | 0.014 | 0.2871 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0018 | 0.003 | 0.003 |
Toxoplasma gondii | thioredoxin reductase | 0.014 | 0.2871 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.014 | 0.2871 | 0.2849 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0048 | 0.0736 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0048 | 0.0736 | 0.5 |
Schistosoma mansoni | galectin | 0.0445 | 1 | 1 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0048 | 0.0736 | 0.0708 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 1 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0048 | 0.0736 | 0.5 |
Loa Loa (eye worm) | galactoside-binding lectin family protein | 0.0445 | 1 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.014 | 0.2871 | 0.2849 |
Plasmodium vivax | thioredoxin reductase, putative | 0.014 | 0.2871 | 1 |
Loa Loa (eye worm) | galactoside-binding lectin family protein | 0.0445 | 1 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.014 | 0.2871 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0048 | 0.0736 | 0.5 |
Brugia malayi | hypothetical protein | 0.0018 | 0.003 | 0.003 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ID50 (functional) | = 0.16 uM | Ability to reduce the cell count to 50% in L1210 culture cells | ChEMBL. | 3339609 |
ID50 (functional) | = 0.16 uM | Ability to reduce the cell count to 50% in L1210 culture cells | ChEMBL. | 3339609 |
K aff (binding) | = 130000 M-1 | Apparent DNA affinity constant | ChEMBL. | 3339609 |
T/C (functional) | Toxic 0 % | Antitumour activity against P388 leukemia in mice at a dose of 50 mg/kg administered intraperitoneally for 5 days | ChEMBL. | 3339609 |
T/C (functional) | = 129 % | Antitumour activity against P388 leukemia in mice at a dose of 10 mg/kg administered intraperitoneally for 5 days | ChEMBL. | 3339609 |
T/C (functional) | = 129 % | Antitumour activity against P388 leukemia in mice at a dose of 10 mg/kg administered intraperitoneally for 5 days | ChEMBL. | 3339609 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.